Akoya Biosciences Inc.

AI Score

0

Unlock

2.66
-0.27 (-9.22%)
At close: Jan 14, 2025, 3:59 PM
2.53
-4.85%
Pre-market Jan 15, 2025, 08:00 AM EST
undefined%
Bid 2.55
Market Cap 131.84M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -1.16
PE Ratio (ttm) -2.29
Forward PE n/a
Analyst Hold
Ask 2.8
Volume 462,046
Avg. Volume (20D) 573,486
Open 3.01
Previous Close 2.93
Day's Range 2.63 - 3.10
52-Week Range 1.88 - 6.31
Beta undefined

About AKYA

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze...

Sector Healthcare
IPO Date Apr 16, 2021
Employees 330
Stock Exchange NASDAQ
Ticker Symbol AKYA

Analyst Forecast

According to 7 analyst ratings, the average rating for AKYA stock is "Hold." The 12-month stock price forecast is $3.5, which is an increase of 31.58% from the latest price.

Buy 42.86%
Hold 57.14%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Akoya Biosciences Inc. is scheduled to release its earnings on Mar 3, 2025, during market hours.
Analysts project revenue of $21.23M, reflecting a -19.85% YoY shrinking and earnings per share of -0.16, making a -27.27% decrease YoY.
2 months ago · Source
-23%
Akoya Biosciences shares are trading lower after t... Unlock content with Pro Subscription
2 months ago · Source
-2.49%
Akoya Biosciences shares are trading lower after the company reported worse-than-expected Q3 financial results.